At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
XAIR Beyond Air, Inc.
Not Yet Opened 08-31 16:00:00 EDT
3.97
-0.51
-11.38%
盘后4.00
+0.03+0.76%
19:59 EDT
High4.52Low3.85Vol8.74M
Open4.52D1 Closing4.48Amplitude14.96%
Mkt Cap3.91MTradable Cap3.48MTotal Shares984.40K
T/O48.54MT/O Rate998.17%Tradable Shares876.00K
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Beyond Air Says FDA Grants Breakthrough Device Tag for LungFit GO in NTM Lung Disease
Reuters  ·  08-31 20:03
Beyond Air Says FDA Grants Breakthrough Device Tag for LungFit GO in NTM Lung Disease
Beyond Air® Receives FDA Breakthrough Device Designation for Lungfit® Go to Treat Nontuberculous Mycobacterial Pulmonary Disease (Ntm-Pd)
THOMSON REUTERS  ·  08-31 20:00
Beyond Air® Receives FDA Breakthrough Device Designation for Lungfit® Go to Treat Nontuberculous Mycobacterial Pulmonary Disease (Ntm-Pd)
Beyond Air Sells NeuroNOS Stake to Univo for 19.99% Equity, up to $32.5 Million Milestones
Reuters  ·  08-25
Beyond Air Sells NeuroNOS Stake to Univo for 19.99% Equity, up to $32.5 Million Milestones
Beyond Air - to Transfer Ip to Neuronos for up to $6.50 Mln Development Milestones
THOMSON REUTERS  ·  08-25
Beyond Air - to Transfer Ip to Neuronos for up to $6.50 Mln Development Milestones
Beyond Air - to Receive 19.99% of Univo Share Capital upon Closing
THOMSON REUTERS  ·  08-25
Beyond Air - to Receive 19.99% of Univo Share Capital upon Closing
Beyond Air Enters Definitive Agreement to Sell Its Neuronos Stake to Univo Pharmaceutical Industries in Exchange for Equity and Milestone Payments
THOMSON REUTERS  ·  08-25
Beyond Air Enters Definitive Agreement to Sell Its Neuronos Stake to Univo Pharmaceutical Industries in Exchange for Equity and Milestone Payments
Beyond Air - Eligible for up to $26 Mln in Commercial Milestone Payments
THOMSON REUTERS  ·  08-25
Beyond Air - Eligible for up to $26 Mln in Commercial Milestone Payments
Beyond Air Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Reuters  ·  08-13
Beyond Air Inc Reports Results for the Quarter Ended June 30 - Earnings Summary
Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook
Reuters  ·  08-13
Beyond Air Q1 Net Loss Slightly Widens, Reaffirms 2026 Outlook
Beyond Air Q1 EPS $(11.00) Misses $(9.40) Estimate, Sales $1.768M Miss $1.929M Estimate
Benzinga Earnings  ·  08-13
Beyond Air Q1 EPS $(11.00) Misses $(9.40) Estimate, Sales $1.768M Miss $1.929M Estimate
Beyond Air - Reaffirms Revenue Guidance of $8 Mln for Cy2026 and $16-$18 Mln for Cy2027
THOMSON REUTERS  ·  08-13
Beyond Air - Reaffirms Revenue Guidance of $8 Mln for Cy2026 and $16-$18 Mln for Cy2027
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
THOMSON REUTERS  ·  08-13
Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
Dow Jones  ·  08-13
Press Release: Beyond Air(R) Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update
Beyond Air Inc Expected to Post a Loss of $10.80 a Share - Earnings Preview
Reuters  ·  08-11
Beyond Air Inc Expected to Post a Loss of $10.80 a Share - Earnings Preview
Beyond Air Effects 1-for-20 Reverse Stock Split
Reuters  ·  08-07
Beyond Air Effects 1-for-20 Reverse Stock Split
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
GlobeNewswire  ·  08-04
Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026
Beyond Air CFO Daniel J. Moorhead Acquires 4,340 Common Shares for $24,998.4
Reuters  ·  08-01
Beyond Air CFO Daniel J. Moorhead Acquires 4,340 Common Shares for $24,998.4
Beyond Air Prices $5.51 Series a and Series B Warrants in $30.1 Million Private Placement
Reuters  ·  07-30
Beyond Air Prices $5.51 Series a and Series B Warrants in $30.1 Million Private Placement
Beyond Air® Announces up to $30.1 Million Private Placement Offering Priced at-the-Market Under NASDAQ Rules
THOMSON REUTERS  ·  07-30
Beyond Air® Announces up to $30.1 Million Private Placement Offering Priced at-the-Market Under NASDAQ Rules
Press Release: Beyond Air(R) Announces up to $30.1 Million Private Placement Offering Priced At-the-Market Under NASDAQ Rules
Dow Jones  ·  07-30
Press Release: Beyond Air(R) Announces up to $30.1 Million Private Placement Offering Priced At-the-Market Under NASDAQ Rules

Introduction

Company Name.
Beyond Air, Inc.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.
Issue price:
--